Drug-development software company
Appears in 1 story
Target of the buyout; to be taken private
Simulations Plus agreed on June 16, 2026 to be taken private by Altaris for $18.50 a share, or about $375 million total. Shareholders get a 26% premium over the prior 60-day average. Altaris plans to fold the company into Chemical Computing Group, a molecular-design firm it already owns.
Updated Jun 17
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
